A new study, which was led by Dr. Martin Miner of Brown University, Massachusetts, has shown that the drug Levitra, which is used to treat erectile dysfunction, is suitable for men with high cholesterol. The results of the study were announced at the 23rd Annual European Association of Urology Congress.
This was the first ever trial conducted which evaluated how Levitra performed in patients who had both high cholesterol levels and erectile dysfunction. The trial, which was carried out with about 400 participants, all of whom had high cholesterol levels, showed that the men who were given Levitra had significant improvements in their ability to gain and maintain an erection when compared with those given a placebo. The trial, which took place over a twelve week period, also showed that the participants who were given Levitra as opposed to the placebo had much better success rates of penetration.
Erectile dysfunction is a common symptom of many complaints that include high cholesterol, high blood pressure or diabetes. Nearly 70 percent of men who suffer with erectile dysfunction have one or more of these conditions.
Erectile dysfunction can also be a marker for testosterone deficiency. The study also showed that testosterone replacement therapy can, as well as improving overall quality of life, improve cardiovascular and metabolic conditions.